ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	9/88	30/7206	4.61925006304e-11
ko04060	Cytokine-cytokine receptor interaction	16/88	191/7206	8.61013541727e-10
ko05152	Tuberculosis	15/88	187/7206	5.61958892665e-09
ko04650	Natural killer cell mediated cytotoxicity	11/88	97/7206	2.01218056785e-08
ko04612	Antigen processing and presentation	10/88	77/7206	2.46447274191e-08
ko04659	Th17 cell differentiation	11/88	106/7206	5.14394713416e-08
ko04658	Th1 and Th2 cell differentiation	10/88	96/7206	2.09831487808e-07
ko05330	Allograft rejection	6/88	24/7206	3.15077661922e-07
ko04640	Hematopoietic cell lineage	8/88	64/7206	9.08455227051e-07
ko05320	Autoimmune thyroid disease	6/88	29/7206	1.05884762534e-06
ko05310	Asthma	5/88	17/7206	1.33544356983e-06
ko05145	Toxoplasmosis	10/88	126/7206	2.659806331e-06
ko05140	Leishmaniasis	8/88	75/7206	3.10463376234e-06
ko04514	Cell adhesion molecules (CAMs)	10/88	130/7206	3.53448420883e-06
ko05416	Viral myocarditis	7/88	55/7206	4.01590136067e-06
ko05150	Staphylococcus aureus infection	6/88	36/7206	4.05426205563e-06
ko05321	Inflammatory bowel disease (IBD)	7/88	56/7206	4.54450944554e-06
ko04660	T cell receptor signaling pathway	9/88	124/7206	1.79965786522e-05
ko04062	Chemokine signaling pathway	11/88	201/7206	2.9556581779e-05
ko05164	Influenza A	10/88	167/7206	3.24352331965e-05
ko04664	Fc epsilon RI signaling pathway	7/88	77/7206	3.83037406517e-05
ko05332	Graft-versus-host disease	4/88	18/7206	5.57611309689e-05
ko05162	Measles	8/88	120/7206	9.89597980754e-05
ko04145	Phagosome	9/88	162/7206	0.000146810781095
ko04064	NF-kappa B signaling pathway	7/88	96/7206	0.000157428726072
ko05144	Malaria	5/88	45/7206	0.000201464981391
ko04620	Toll-like receptor signaling pathway	7/88	100/7206	0.000203261298847
ko04380	Osteoclast differentiation	8/88	134/7206	0.00021361049343
ko05168	Herpes simplex infection	9/88	182/7206	0.000351873878674
ko03050	Proteasome	5/88	54/7206	0.000478421398932
ko04940	Type I diabetes mellitus	4/88	32/7206	0.000575133452304
ko04666	Fc gamma R-mediated phagocytosis	7/88	122/7206	0.000685008628241
ko04672	Intestinal immune network for IgA production	4/88	37/7206	0.00100835002014
ko04610	Complement and coagulation cascades	5/88	79/7206	0.00268565374344
ko05166	HTLV-I infection	10/88	292/7206	0.00281041758379
ko05133	Pertussis	5/88	87/7206	0.00408045985593
ko04662	B cell receptor signaling pathway	5/88	88/7206	0.00428535534875
ko05323	Rheumatoid arthritis	5/88	89/7206	0.00449750479837
ko04630	Jak-STAT signaling pathway	6/88	132/7206	0.00535574138992
ko04217	Necroptosis	7/88	178/7206	0.00588691722654
ko05167	Kaposi's sarcoma-associated herpesvirus infection	7/88	191/7206	0.00856219772826
ko04670	Leukocyte transendothelial migration	6/88	151/7206	0.0101386988898
ko05322	Systemic lupus erythematosus	6/88	151/7206	0.0101386988898
ko04611	Platelet activation	6/88	163/7206	0.0143991046996
ko05161	Hepatitis B	6/88	173/7206	0.0187986823224
ko04144	Endocytosis	9/88	342/7206	0.0366257744339
ko05169	Epstein-Barr virus infection	6/88	206/7206	0.0396361886862
ko04621	NOD-like receptor signaling pathway	5/88	157/7206	0.0425624932876